Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Platinum Compounds × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 13 Lung Neoplasms 2 Esophageal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sjogren's Syndrome 1 Scleroderma, Systemic 1 Retinoblastoma 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Resectable Non-small Cell Lung Cancer 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrence 1 Psoriasis 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Sclerosis 1 Lupus Erythematosus, Systemic 1 Inflammatory Bowel Diseases 1 Hematologic Neoplasms 1 Dermatomyositis 1 Crohn Disease 1 Colitis, Ulcerative 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Bronchogenic 1 Bronchial Neoplasms 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1 Arthritis, Psoriatic 1 Advanced Non-small Cell Lung Cancer 1

Interventions

Cyclophosphamide 21 venetoclax 19 Dexamethasone 17 pembrolizumab 16 fludarabine 14 Cytarabine 13 Gemcitabine 10 Azacitidine 9 pomalidomide 8 Rituximab 8 Lenalidomide 8 Carboplatin 8 selinexor 7 glofitamab 7 fludarabine phosphate 7 Cisplatin 7 daratumumab 6 Temozolomide 6 Paclitaxel 6 Injections 6 Immunotherapy, Adoptive 6 Granulocyte Colony-Stimulating Factor 6 Oxaliplatin 5 Decitabine 5 Bevacizumab 5 ruxolitinib 4 Surgical Procedures, Operative 4 Nivolumab 4 Drug Therapy 4 Cladribine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07340164 2026-04-20

TROY

Yonsei University

Phase 2 Recruiting

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡